Barclays analyst Julian Mitchell lowered the firm’s price target on Emerson (EMR) to $105 from $110 and keeps an Underweight rating on the shares. The firm adjusted targets in the multi-industry group as part of a Q1 preview. It sees revenue and margin pressure alongside lower investor expectations.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EMR: